Gene · 406920
Papers2,391
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,391
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PAK1 overexpression promotes myxofibrosarcoma angiogenesis through STAT5B-mediated CSF2 transactivation: clinical and therapeutic relevance of amplification and nuclear entry. | Int J Biol Sci | 2023 | 37564209 | PubTator, text mining | PubMed |
| BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution. | Theranostics | 2023 | 37554265 | PubTator, text mining | PubMed |
| Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients. | Front Oncol | 2023 | 37546401 | PubTator, text mining | PubMed |
| Peripheral origin exosomal microRNAs aggravate glymphatic system dysfunction in diabetic cognitive impairment. | Acta Pharm Sin B | 2023 | 37521866 | PubTator, text mining | PubMed |
| Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer-Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects. | Int J Mol Sci | 2023 | 37511115 | PubTator, text mining | PubMed |
| Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis. | Biomedicines | 2023 | 37509493 | PubTator, text mining | PubMed |
| Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons. | Cells | 2023 | 37508559 | PubTator, text mining | PubMed |
| Knockdown of KLF5 ameliorates renal fibrosis in MRL/lpr mice via inhibition of MX1 transcription. | Immun Inflamm Dis | 2023 | 37506140 | PubTator, text mining | PubMed |
| The role of Extracellular Genomic Materials (EGMs) in psychiatric disorders. | Transl Psychiatry | 2023 | 37464177 | PubTator, text mining | PubMed |
| Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development. | J Transl Med | 2023 | 37461108 | PubTator, text mining | PubMed |
| Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer. | Front Oncol | 2023 | 37456240 | PubTator, text mining | PubMed |
| Role of MicroRNAs in Cancer Development and Treatment. | Int J Mol Sci | 2023 | 37446236 | PubTator, text mining | PubMed |
| Small RNA Profiling in an HTLV-1-Infected Patient with Acute Adult T-Cell Leukemia-Lymphoma at Diagnosis and after Maintenance Therapy: A Case Study. | Int J Mol Sci | 2023 | 37445821 | PubTator, text mining | PubMed |
| Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer. | Int J Mol Sci | 2023 | 37445798 | PubTator, text mining | PubMed |
| MicroRNAs in Tumor Endothelial Cells: Regulation, Function and Therapeutic Applications. | Cells | 2023 | 37443725 | PubTator, text mining | PubMed |
| miR-146b-5p promotes duck Tembusu virus replication by targeting RPS14. | Poult Sci | 2023 | 37441905 | PubTator, text mining | PubMed |
| Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome. | Front Genet | 2023 | 37434949 | PubTator, text mining | PubMed |
| Emerging diversity in extracellular vesicles and their roles in cancer. | Front Oncol | 2023 | 37397375 | PubTator, text mining | PubMed |
| Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. | Int J Oral Sci | 2023 | 37386003 | PubTator, text mining | PubMed |
| Construction of a Diagnostic Model and a lncRNA-Associated ceRNA Network Based on Apoptosis-Related Genes for Schizophrenia. | Behav Neurol | 2023 | 37383091 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406920/papers?page=7